Thread by @LuoshengPeng

Hi! How have you been on the 1st day of 2021? Hope it has been meaningful & joyful, or relaxing.

The 1st sharing for the new year is a biotech investor's predictions for 2021.

The most interesting ones are:

1/

businessinsider.com/brad-loncar-bi…

- March-in rights, which allow the US gov to effectively cancel patents on a drug that federal research helped develop & it is the biggest thing that can sink biotech or give it some major heartburn

2/

- Gene-editing stocks will have at least a 30%-40% correction from today's prices & it also includes biotechs working on sequencing technology & base editing

- CV19 will be largely controlled in the US by the end of the summer

3/

- SPACs will fizzle out in popularity & use as SPACs do a good job of making money for the people behind them but they are inefficient at returning value to the final shareholders

4/

- The most over-hyped area within biotech will be anti-aging & new IPOs in the space will drive excitement in the new year

- At least two CD47 companies will be acquired & $TRIL $ALXO $IMAB are biotechs working on CD47 drugs

5/

- 2021's scary theme will transition from the pandemic to climate change

6/end

These predictions may not necessarily be all right, but giving you food for thought.